Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
98.33B | 99.30B | 98.46B | 98.46B | 88.79B | 114.24B | Gross Profit |
6.65B | 6.62B | 6.68B | 6.77B | 5.93B | 6.80B | EBIT |
819.00M | 688.00M | 830.00M | 432.00M | -190.00M | -81.00M | EBITDA |
1.03B | 994.00M | 1.18B | 632.00M | -111.00M | 58.00M | Net Income Common Stockholders |
892.00M | 1.19B | 1.01B | 701.00M | -18.00M | 653.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.11B | 3.00B | 4.34B | 2.93B | 2.28B | 3.58B | Total Assets |
30.49B | 24.84B | 24.75B | 22.49B | 21.07B | 20.16B | Total Debt |
4.85B | 3.00B | 2.90B | 4.10B | 3.20B | 2.70B | Net Debt |
1.74B | -1.00M | -1.44B | 1.19B | 917.00M | -875.00M | Total Liabilities |
19.73B | 13.38B | 14.70B | 14.26B | 13.52B | 12.49B | Stockholders Equity |
10.76B | 11.46B | 10.04B | 8.23B | 7.55B | 7.67B |
Cash Flow | Free Cash Flow | ||||
0.00 | -1.34B | 2.57B | -402.00M | -2.11B | 222.00M | Operating Cash Flow |
0.00 | -1.06B | 2.65B | -349.00M | -2.00B | 285.00M | Investing Cash Flow |
0.00 | -296.00M | 227.00M | 123.00M | 280.00M | 338.00M | Financing Cash Flow |
0.00 | 12.00M | -1.27B | 841.00M | 428.00M | -194.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥4.25B | 29.15 | ― | 8.10% | -26.52% | ||
75 Outperform | ¥2.97B | 11.53 | 1.82% | 14.88% | 8.27% | ||
72 Outperform | ¥13.94B | 4.81 | 3.15% | 8.95% | 35.94% | ||
68 Neutral | ¥4.21B | 3.60 | 1.90% | 0.86% | 17.26% | ||
65 Neutral | $8.92B | 15.03 | 4.68% | 6.11% | 3.59% | -2.49% | |
61 Neutral | ¥8.71B | 30.17 | 0.90% | 6.33% | 40.87% | ||
58 Neutral | ¥2.69B | 86.11 | 0.95% | 0.80% | -25.72% |